Genetics of colorectal cancer

ONCOLOGY

Volumn 20, Issue 3, 2006, Pages 269-276

  Jeter, Joanne M ^a   Kohlmann, Wendy ^a   Gruber, Stephen B ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Box 0638 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ENEMA; FLUOROURACIL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN; ROFECOXIB; SULINDAC;

ADENOMATOUS POLYP; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COLON RESECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; ENDOSCOPY; FAMILIAL CANCER; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HEPATOBLASTOMA; HEREDITY; HUMAN; IMAGING; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MORBIDITY; MYH GENE; ONCOGENE; PATHOGENESIS; PEUTZ JEGHERS SYNDROME; PHENOTYPE; REVIEW; ALLELE; COLORECTAL TUMOR; DISEASE PREDISPOSITION; GENETIC SCREENING; GENETICS; MUTATION; RISK ASSESSMENT; RISK FACTOR;

ALLELES; COLORECTAL NEOPLASMS; DISEASE SUSCEPTIBILITY; GENETIC SCREENING; HUMANS; MUTATION; RISK ASSESSMENT; RISK FACTORS;

EID: 33745612779     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Burt RW, Petersen GM: Familial colorectal cancer: Diagnosis and management, in Young GP, Rozen P, Levin B (eds): Prevention and Early Detection of Colorectal Cancer, pp 171-194. Philadelphia, WB Saunders, 1996.
2. Bulow S: Familial polyposis coli. Dan Med Bull 34:1-15, 1987.
3. Knudsen BM, Bulow S: Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Familial Cancer 2:43-55, 2003.
4. Burt RW: Gastric fundic gland polyps. Gastroenterology 125:1462-1469, 2003.
5. Kadmon M, Tandara A, Herfarth C: Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register. Int J Colorectal Dis 16:63-75, 2001.
6. Gardner EJ, Richards RC: Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 5:139-147, 1953.
7. Tourino R, Conde-Friere R, Cabezas-Agricola JM, et al: Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis. International Ophthalmology 25:101-112, 2004.
8. Giardiello FM, Offerhaus GJA, Lee DH, et al: Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 34:1394-1396, 1993.
9. Hamilton SR, Liu B, Parsons RE, et al: The molecular basis of Turcot's syndrome. N Engl J Med 332:839-847, 1995.
10. Merg A, Lynch HT, Lynch JF, et al: Hereditary colon cancer - part I. Curr Probl Surg 42:195-256, 2005.
11. Groden J, Thliveris A, Samowitz W, et al: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600, 1991.
12. Kinzler KW, Nilbert MC, Su L-K, et al: Identification of FAP locus genes from chromosome 5q21. Science 253:661-665, 1991.
13. Spirio L, Olschwang S, Groden J, et al: Alleles of the APC gene: An attenuated form of familial polyposis. Cell 75:951-957, 1993.
14. van der Luijt RB, Vasen HFA, Tops CMJ, et al: APC mutation in the alternatively spliced region of exon 9 associated with late onset familial adenomatous polyposis. Hum Genet 96:705-710, 1995.
15. Friedl W, Meuschel S, Caspari R, et al: Attenuated familial adenomatous polyposis due to a mutation in the 3′ part of the APC gene. A clue for understanding the function of the APC protein. Hum Genet 97:579-584, 1996.
16. Jarvinen HJ, Peltomaki P: The complex genotype-phenotype relationship in familial adenomatous polyposis. Eur J Gastroenterol Hepatol 16:5-8, 2004.
17. Cromwell DM, Moore RD, Brensinger JD, et al: Cost analysis of alternative approaches to colorectal screening in familial adenomatous polyposis. Gastroenterology 114:893-901, 1998.
18. Spigelman AD: Familial adenomatous polyposis and the upper gastrointestinal tract. Sem Colon Rectal Surg 6:26-28, 1995.
19. Lynch HT, de la Chappelle A: Hereditary colorectal cancer. N Engl J Med 348:919-932, 2003.
20. Lynch HT, Lynch J: Lynch syndrome: Genetics, natural history, genetic counseling, and prevention. J Clin Oncol 18:19s-31s, 2000.
21. Aarnio M, Mecklin J-P, Aaltonen LA, et al: Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64:430-433, 1995.
22. Vasen HF, Mecklin J-P, Khan PM, et al: The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICGHNPCC). Dis Colon Rectum 34:424-425, 1991.
23. Vasen HF, Watson P, Mecklin J-P, et al: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453-1456, 1999.
24. Lipton LR, Johnson V, Cummings C, et al: Refining the Amsterdam Criteria and Bethesda Guidelines: Testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol 22:4934-4943, 2004.
25. Ionov Y, Peinado MA, Malkhosyan S, et al: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558-561, 1993.
26. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon. Science 260:816-819, 1993.
27. Peltomaki P, Aaltonen LA, Sistonen P, et al: Genetic mapping of a locus predisposing to human colorectal cancer. Science 260:810-812, 1993.
28. Aaltonen LA, Peltomaki P, Leach FS, et al: Clues to the pathogenesis of familial colorectal cancer. Science 260:812-816, 1993.
29. Liu B, Parsons R, Papadopoulos N, et al: Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer. Nature Medicine 2:169-174, 1996.
30. Cunningham JM, Kim C-Y, Christensen ER, et al: The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 69:780-790, 2001.
31. Casey G, Lindor NM, Papadopoulos N, et al: Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. JAMA 293:799-809, 2005.
32. Lindor NM, Rabe K, Petersen GM, et al: Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: Familial colorectal cancer type X. JAMA 293:1979-1985, 2005.
33. Syngal S, Fox EA, Eng C, et al: Sensitivity and specificity of clinical criteria for hereditary nonpolyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 37:641-645, 2000.
34. Watson P, Lin KM, Rodriguez-Bigas MA, et al: Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer 83:259-266, 1998.
35. Popat S, Hubner R, Houlston RS: Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23:609-618, 2005.
36. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89:1758-1762, 1997.
37. Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268, 2004.
38. Hampel H, Frankel WL, Martin E, et al: Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352:1851-1860, 2005.
39. Jarvinen HJ, Aarnio M, Mustonen H, et al: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834, 2000.
40. National Comprehensive Cancer Network: Colorectal cancer screening: Clinical practice guidelines in oncology. J Natl Compr Canc Netw 1:72-93, 2003.
41. Deligeoroglou E, Michailidis E, Creatsas G: Oral contraceptives and reproductive system cancer. Ann NY Acad Sci 997:199-208, 2003.
42. Al-Tassan N, Chmiel NH, Maynard J, et al: Inherited variants of MYH associated with somatic G:C - >T:A mutations in colorectal tumors. Nature Genetics 30:227-232, 2002.
43. Croitoru M, Cleary SP, Di Nicola N, et al: Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 96:1631-1634, 2004.
44. Sieber OM, Lipton L, Crabtree M, et al: Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348:791-799, 2003.
45. Jass J, Williams CB, Bussey HJ, et al: Juvenile polyposis - a precancerous condition. Histopathology 13:619-630, 1988.
46. Gallione C, Repetto GM, Legius E, et al: A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363:852-859, 2004.
47. Schreibman I, Baker M, Amos C, et al: The hamartomatous polyposis syndromes: A clinical and molecular review. Am J Gastroenterol 100:476-490, 2005.
48. Starink T, van der Veen JP, Arwert F, et al: The Cowden syndrome: A clinical and genetic study in 21 patients. Clinical Genetics 29:222-233, 1986.
49. Bartholomew LG, Dahlin DC, Waugh JM: Intestinal polyposis associated with mucocutaneous melanin pigmentation (Peutz-Jeghers syndrome): Review of the literature and report of six cases with special reference to pathologic findings. Gastroenterology 32:434-451, 1957.
50. Giardiello FM, Brensinger JD, Tersmette AC, et al: Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119:1447-1453, 2000.
51. Boardman LA, Thibodeau SN, Schaid DJ, et al: Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 128:896-899, 1998.
52. Giardiello FM, Welsh SB, Hamilton SR, et al: Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316:1511-1514, 1987.
53. Gruber SB, Entius MM, Petersen GM, et al: Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res 58:5267-5270, 1998.
54. Laken SJ, Petersen GM, Gruber SB, et al: Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genetics 17:79-83, 1997.
55. Strul H, Barenboim E, Leshno M, et al: The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews. Cancer Epidemiol Biomarkers Prev 12:1012-1015, 2003.
56. Pasche B, Kaklamani V, Hou N, et al: TGFBR1*6A and cancer: A meta-analysis of 12 case-control studies. J Clin Oncol 22:756-758, 2004.
57. de la Chapelle A: Genetic predisposition to colorectal cancer. Nat Rev Cancer 4:769-780, 2004.
58. Houlston RS, Tomlinson IP: Polymorphisms and colorectal tumor risk. Gastroenterology 121:282-301, 2001.
59. Gruber SB, Ellis NA, Scott KK, et al: BLM heterozygosity and the risk of colorectal cancer. Science 297(5589):2013, 2002.
60. Cleary SP, Zhang W, Di Nicola N, et al: Heterozygosity for the BLM(Ash) mutation and cancer risk. Cancer Res 63:1769-1771, 2003.